Loading IPO Details...
Upcoming IPOs
Cement & Cement Products · Listed on BSE , NSE · 15 Oct 2026 - 19 Oct 2026
Jagat JoshiIncorporated in 2001, Sahajanand Medical Technologies is a medical device firm that focuses on Class III and Class C/D devices, mainly working in the fields of vascular and structural heart intervention. The company was the first globally to achieve CE certification for a drug-eluting stent (DES) with a biodegradable polymer, Infinnium. Its product range is divided into 3 main categories: Vascular Intervention (VI), Structural Heart (SH), and other products.
Sahajanand operates two R&D centers, one in India & one in Thailand, backed by a team of 102 professionals such as biomedical engineers and clinical research specialists. Moreover, its key products such as Supraflex Cruz (DES), Hydra (TAVI), and Cocoon (Occluders) are backed by 72 clinical studies and are widely known in over 76 countries across Europe, Asia, and other regions.
| Date & Time | GMP (₹) | Est. Listing Price | Est. Gain (%) | Est. Profit / Lot (₹) |
|---|---|---|---|---|
| 21-Oct-2026 11:34 AM | +₹24 | ₹368 | +6.98% | ₹1,032 |
| 20-Oct-2026 11:34 AM | +₹25 | ₹369 | +7.27% | ₹1,075 |
| 19-Oct-2026 11:34 AM | +₹25 | ₹369 | +7.27% | ₹1,075 |
| 17-Oct-2026 11:33 AM | +₹15 | ₹359 | +4.36% | ₹645 |
| 16-Oct-2026 06:00 PM | +₹40 | ₹384 | +11.63% | ₹1,720 |
| 15-Oct-2026 06:00 PM | +₹45 | ₹389 | +13.08% | ₹1,935 |
| 14-Oct-2026 06:00 PM | +₹42 | ₹386 | +12.21% | ₹1,806 |
| 13-Oct-2026 06:00 PM | +₹42 | ₹386 | +12.21% | ₹1,806 |
| 12-Oct-2026 05:00 PM | +₹46 | ₹390 | +13.37% | ₹1,978 |
| 11-Oct-2026 05:00 PM | +₹40 | ₹384 | +11.63% | ₹1,720 |
| Category | Subscription (x) | Shares Offered | Shares bid for | Total Amount (₹ Cr) |
|---|---|---|---|---|
| Anchor | 1.00x | 40,71,634 | 40,71,634 | ₹140.06 Cr |
| QIB (Ex. Anchor) | 34.70x | 27,14,424 | 9,41,79,804 | ₹3,239.79 Cr |
| NII | 14.64x | 20,35,817 | 2,98,12,072 | ₹1,025.54 Cr |
| bNII > ₹10L | 11.20x | 13,57,212 | 1,52,00,774 | ₹522.91 Cr |
| sNII < ₹10L | 16.37x | 6,78,606 | 1,11,08,780 | ₹382.14 Cr |
| Retail | 3.05x | 47,50,241 | 1,44,75,477 | ₹497.96 Cr |
| Employees | 0.37x | 2,50,000 | 92,880 | ₹3.20 Cr |
| Total | 10.32x | 1,38,22,116 | 14,26,31,867 | ₹4,906.54 Cr |
| Period Ended | 30 JUN 2026 | 31 MAR 2026 | 31 MAR 2025 | 31 MAR 2024 |
|---|---|---|---|---|
| Total Income | 354.33 | 1218.73 | 1035.96 | 908.59 |
| Profit After Tax | 15.09 | 69.08 | 25.15 | -7.35 |
| EBITDA | 48.58 | 170.66 | 128.02 | 110.05 |
| NET Worth | 631.72 | 616.05 | 545.23 | 526.30 |
| Reserves and Surplus | 706.86 | 692.48 | 580.71 | 556.57 |
| Total Borrowing | 320.63 | 269.53 | 224.96 | 175.27 |
| Company Name | EPS (₹) | P/E (x) | NAV (₹) | RoNW (%) | Income (₹ Cr) |
|---|---|---|---|---|---|
| Laxmi Dental Limited | 5.27 | 36.35 | 44.27 | 11.91 | 277.86 |
| Poly Medicure Limited | 31.79 | 51.40 | 306.40 | 10.37 | 1,875.26 |
Bhargav Dhirajlal Kotadia, Dhirajlal Vallabhbhai Kotadia, Priyanka Dhirajlal Cohen and Shree Hari Trust. is the company's promoter of Sahajanand Medical Technologies .
| Particular | Pre IPO | Post IPO |
|---|---|---|
| Promoter and Promoter Group | 40.82% | 36.20% |
| Others* | 59.18% | 63.80% |
Join the discussion
Please sign in to leave a comment or reply.